Skip to main content

ChEMBL 32 is released!

 

We are pleased to announce the release of ChEMBL 32! This release of ChEMBL comes with a complete update of drug and clinical candidate information, the addition on a Natural Product likeness score and a harmonization of Journal Name abbreviations according to NLM standards.

This version of the database, prepared on 26/01/2023 contains:

  • 2,354,965 compounds (of which 2,327,928 have mol files)            
  • 2,995,433 compound records (non-unique compounds)
  • 20,038,828 activities
  • 1,536,903 assays
  • 15,139 targets
  • 86,364 documents

 

Please see ChEMBL 32 release notes for full details of all changes in this release. Data can be downloaded from the ChEMBL FTP site.

Please note that on demand Oracle 19c dumps will not be provided anymore after the ChEMBL 34 release.

New Deposited Datasets

  • CHEMBL5058649 - Data for DCP probe BAY 1816032*
  • CHEMBL5058643 - Data for DCP probe BI-2081*
  • CHEMBL5058646 - Data for DCP probe CCT369260*
  • CHEMBL5058644 - Data for DCP probe JNJ-39758979*
  • CHEMBL5058645 - Data for DCP probe JNJ-6204*
  • CHEMBL5058647 - Data for DCP probe JNJ-9350*
  • CHEMBL5058648 - Data for DCP probe SAFit2*
  • CHEMBL5058641 - Data for DCP probe TP-050*
  • CHEMBL5058642 - Data for DCP probe TP-051*
  • CHEMBL5060014 - EUbOPEN Chemogenomics Library wave 2 - DSF
  • CHEMBL5069381 - ITC assay results for EUbOPEN Chemical Probe Library
  • CHEMBL5095002 - International Nonproprietary Names for Pharmaceutical Substances (INN)
  • CHEMBL5058564 - Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library 2 (Incuyte)
  • CHEMBL5058577 - Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library 2 (Multiplex)
  • CHEMBL5058541 - Tm Shift (DSF) assay results for EUbOPEN Chemogenomics Library 2 (NanoBRET)

* = All part of the Donated Chemical Probes source


New Sources

  • International Nonproprietary Names


Updated Sources

  • Scientific Literature (spanning publication dates from March 1974 until  April 2022)
  • Orange Book
  • Clinical Candidates
  • Patent Bioactivity Data
  • USP Dictionary of USAN and International Drug Names
  • Prodrug active ingredients
  • Manually Added Drugs
  • Donated Chemical Probes (DCP) - SGC Frankfurt
  • WHO Anatomical Therapeutic Chemical Classification
  • Withdrawn Drugs
  • EUbOPEN Chemogenomic Library


Database changes since the last release

Journal names have been harmonised and standardised according to the National Library of Medicine (NLM) standards.

Tables that have been deprecated since ChEMBL 31

  • PROTEIN_FAMILY_CLASSIFICATION


Fields that have been deprecated since ChEMBL 31

  • MOLECULE_DICTIONARY.WITHDRAWN_YEAR
  • MOLECULE_DICTIONARY.WITHDRAWN_COUNTRY
  • MOLECULE_DICTIONARY.WITHDRAWN_REASON
  • MOLECULE_DICTIONARY.WITHDRAWN_CLASS
  • MOLECULE_DICTIONARY.NATURAL_PRODUCT
  • USAN_STEMS.WHO_EXTRA


Fields that have been added since ChEMBL 31

  • COMPOUND_PROPERTIES.NP_LIKENESS_SCORE
  • DRUG_WARNING.EFO_TERM
  • DRUG_WARNING.EFO_ID
  • DRUG_WARNING.EFO_ID_FOR_WARNING_CLASS


Field types that have been changed into FLOAT since ChEMBL 31

  • MOLECULE_DICTIONARY.MAX_PHASE
  • DRUG_INDICATION.MAX_PHASE_FOR_IND



If you require further information about ChEMBL, please contact us: chembl-help@ebi.ac.uk

  • To receive updates when new versions of ChEMBL are available, please sign up to our mailing list: http://listserver.ebi.ac.uk/mailman/listinfo/chembl-announce
  • For general queries/feedback please email: chembl-help@ebi.ac.uk
  • For details of upcoming webinars, please see: http://chembl.blogspot.com/search/label/Webinar

 

Comments

Popular posts from this blog

Here's a nice Christmas gift - ChEMBL 35 is out!

Use your well-deserved Christmas holidays to spend time with your loved ones and explore the new release of ChEMBL 35!            This fresh release comes with a wealth of new data sets and some new data sources as well. Examples include a total of 14 datasets deposited by by the ASAP ( AI-driven Structure-enabled Antiviral Platform) project, a new NTD data se t by Aberystwyth University on anti-schistosome activity, nine new chemical probe data sets, and seven new data sets for the Chemogenomic library of the EUbOPEN project. We also inlcuded a few new fields that do impr ove the provenance and FAIRness of the data we host in ChEMBL:  1) A CONTACT field has been added to the DOCs table which should contain a contact profile of someone willing to be contacted about details of the dataset (ideally an ORCID ID; up to 3 contacts can be provided). 2) In an effort to provide more detailed information about the source of a deposited dat...

Improvements in SureChEMBL's chemistry search and adoption of RDKit

    Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL . This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second. The similarity search relies on 256-bit RDKit -calculated ECFP4 fingerprints, and a single instance requires approximately 1 GB of RAM to run. SureChEMBL’s FPSim2 file is not currently available for download, but we are considering generating it periodicaly and have created it once for you to try in Google Colab ! For substructure searches, we now also use an RDKit -based solution via SubstructLibrary , which returns results several times faster than our previous implementation. Additionally, structure search results are now sorted by...

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding ...

Improved querying for SureChEMBL

    Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never ...

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen...